BriaCell Therapeutics' lead candidate, Bria-IMT, shows promising trial results for metastatic breast cancer, potentially doubling overall survival and median progression-free survival. Despite a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback